Documentation Mailing Lists FAQ Roadmap - Questionaire Responses for AA CAMP 2004

Add new suggestion (editors)
Add new suggestion (techies/administrators)

1. Main problems and annoyances you encounter when using ActionApps
What qualifications have you got? http://www.wastec.com.br/ibuprofene-600mg-prezzo-bkqx para que serve o comprimido ibuprofeno 600mg Sales of Pomalyst - Celgene's new multiple myeloma drug forpatients who have received treatment with at least two priortherapies - were $90 million, up 35 percent from the secondquarter. That included $77 million in the United States,outpacing Amgen Inc's new rival drug Kyprolis, whichhad sales of $65 million in the third quarter.

2. Features suggested for future development versions of ActionApps
What qualifications have you got? http://www.wastec.com.br/ibuprofene-600mg-prezzo-bkqx para que serve o comprimido ibuprofeno 600mg Sales of Pomalyst - Celgene's new multiple myeloma drug forpatients who have received treatment with at least two priortherapies - were $90 million, up 35 percent from the secondquarter. That included $77 million in the United States,outpacing Amgen Inc's new rival drug Kyprolis, whichhad sales of $65 million in the third quarter.

3. Comments About Usablility
What qualifications have you got? http://www.wastec.com.br/ibuprofene-600mg-prezzo-bkqx para que serve o comprimido ibuprofeno 600mg Sales of Pomalyst - Celgene's new multiple myeloma drug forpatients who have received treatment with at least two priortherapies - were $90 million, up 35 percent from the secondquarter. That included $77 million in the United States,outpacing Amgen Inc's new rival drug Kyprolis, whichhad sales of $65 million in the third quarter.

4. General future development suggestions
n/a

Submited by:
IwaPTLoyqQYBFnz

Mar 6 2021

APC ActionApps is a free software content management system initiated by the Association for Progressive Communications (APC) APC - Internet and ICTs for social justice and development